Skip to content

Corpuls

Corpuls is the medical technology brand of GS Elektromedizinische Geräte G. Stemple GmbH, offering products and systems for emergency and intensive care medicine.

Last updated October 5, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Corpuls is the brand name of GS Elektromedizinische Geräte G. Stemple GmbH. This German medical technology provider, headquartered in Kaufering, Bavaria, develops products and system solutions for emergency and intensive care medicine. Its product portfolio is described as including defibrillators, monitoring systems, chest compression devices, and digital solutions for telemedicine and data and quality management. The company was founded by Günter Stemple in 1982 and initially focused on selling portable defibrillators. According to the company profile provided, its products are sold in 75 countries worldwide. In addition to its headquarters in Kaufering, the company has locations in Igling, Augsburg, Potsdam, Lübeck, Landau, Munich, and Cologne in Germany, as well as locations in Austria, Denmark, Malaysia, and Peru. After founder Günter Stemple retired in 2021, his son Klaus Stemple, daughter Iris Klimmer, and son-in-law Christian Klimmer took over the business. Nordic Capital became the company's majority shareholder in 2023. The brand's website states that it is preparing to bring its expertise to the U.S. market, while noting that at the time of the notice, the products were not yet sold in the United States.

History

Corpuls is the brand name of GS Elektromedizinische Geräte G. Stemple GmbH, a German medical technology company headquartered in Kaufering, Bavaria. Its stated focus is the development of products and system solutions for emergency and intensive care medicine. Günter Stemple founded the company in 1982. In its early period, it primarily sold a portable defibrillator. The company's portfolio later encompassed defibrillators, monitoring systems, chest-compression devices, and digital solutions for telemedicine and data and quality management. The supplied company profile says the products are distributed in 75 countries. It also identifies company locations in several German cities and in Austria, Denmark, Malaysia, and Peru. A change in family leadership followed the founder's retirement in 2021: his son Klaus Stemple, daughter Iris Klimmer, and son-in-law Christian Klimmer took over the business. In 2023, the Swedish financial investor Nordic Capital became majority owner. The supplied official-site notice indicates an intention to bring Corpuls's expertise to the U.S. market, while explicitly stating that its products were not available for sale there at the time of the notice.

  • 2023

    Nordic Capital becomes majority owner

  • 2021

    Founder retires and family members take over

  • 1982

    Company founded

Products and positioning

A German medical technology brand focused on products and system solutions for emergency and intensive care medicine.

  • Defibrillators

    The company initially focused mainly on selling a portable defibrillator; defibrillators remain part of its stated portfolio.

  • Monitoring systems

    Listed as part of the company's portfolio for emergency and intensive care medicine.

  • Chest-compression devices

    Listed as part of the company's product portfolio.

  • Digital solutions

    Solutions for telemedicine and data and quality management.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/corpuls · Editorial policy · How profiles are compiled